Ozempic, which contains semaglutide, has been approved by the U.S. Food and Drug Administration (FDA) for managing type 2 diabetes. It helps regulate blood sugar by boosting insulin production from the pancreas. The drug is also used to lower the chance of cardiovascular issues in diabetic patients. One notable and well-known effect of Ozempic is its ability to aid in weight loss when administered as a weekly injection.
Individuals are filing lawsuits against Ozempic, claiming that the drug, semaglutide, may cause severe gastrointestinal issues such as gastroparesis, ileus and intestinal blockages.
As the drug’s usage increases, concerns have emerged about the possibility of serious gastrointestinal injuries from prolonged use. Our firm is currently investigating Ozempic lawsuits related to diagnoses including:
- Gastroparesis (stomach paralysis)
- Ileus (bowel blockage)
- Vision problems, including non-arthritic anterior ischemic optic neuropathy (NAION)
- Bile duct cancer
- Lou Gehrig’s disease (ALS)
- Gallbladder cancer
- Sinus cancer
- Deep vein thrombosis (DVT) or pulmonary embolism (PE)
- Blood clots
If you have been diagnosed with any of these conditions or have experienced severe and prolonged vomiting, please contact us immediately for a free evaluation of your Ozempic lawsuit.
Hupy and Abraham is now accepting cases for individuals who have experienced adverse effects or complications from the use of Ozempic. If you or a loved one has been impacted, reach out to us for a consultation to discuss your legal options. To learn more, please contact the experienced mass tort lawyers of Hupy and Abraham today for a free, no-obligation consultation at hupy.com. We will fight hard to get you the fair and just compensation that you deserve.
